alexa

GET THE APP

An Update on the Gut Microbiome and the Use of Probiotics for Disease Prevention in Preterm Infants | OMICS International| Abstract
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Epidemiology (Sunnyvale) 2018, Vol 8(1): 339
  • DOI: 10.4172/2161-1165.1000339

An Update on the Gut Microbiome and the Use of Probiotics for Disease Prevention in Preterm Infants

Hyun Ju Lee*
Department of Pediatrics, Hanyang University Seoul Hospital, , 17 Haengdang-dong, Seongdong-gu, Seoul 133-792, Korea
*Corresponding Author : Hyun Ju Lee, Department of Pediatrics, Hanyang University Seoul Hospital, Hanyang University, 17 Haengdang-dong, Seongdong-gu, Seoul 133-792, Korea, Tel: 82-2-2290-8399, Email: [email protected]

Received Date: Jan 07, 2018 / Accepted Date: Feb 20, 2018 / Published Date: Feb 28, 2018

Abstract

Very low birth weight infants (VLBWIs) are at high risk for inflammatory diseases including necrotizing enterocolitis (NEC) or neonatal sepsis, which are primary causes of neonatal mortality. The intestinal microbiota plays an essential role in maintaining local immune homeostasis and enhancing the intestinal barrier in preterm infants; however, appropriate intestinal colonization with normal flora after birth is interrupted by immature gastrointestinal tract, intestinal mucosal damage, insufficient nutrient transport, or formation of abnormal intestinal flora due to the use of antimicrobials in VLBWIs. Large randomized controlled trials and meta-analyses have highlighted the potential benefits of the clinical use of probiotics on NEC or neonatal sepsis for immunologically immature VLBWIs. However, standardized guidelines for the optimum strain, combination of strains, dosage, timing, and duration of probiotics are unknown for the routine application of probiotics in VLBWIs. Here, we review the results of previous studies on the effects of probiotics in preventing morbidity, NEC, or neonatal sepsis in VLBWIs with the administration of single-strain or multi-strain probiotics. Future clinical trials should address the safety of each probiotic strain and the potential efficacy of strain combinations for the routine use of probiotics in preterm infants. The key findings of the manuscript: This study reviewed the focus on the efficacy of probiotics for the prevention of sepsis and necrotizing enterocolitis in preterm infants weighing less than 1,500 g at birth according to single-strain probiotics or multi-strain probiotics.

Citation: Lee HJ (2018) An Update on the Gut Microbiome and the Use of Probiotics for Disease Prevention in Preterm Infants. Epidemiology (Sunnyvale) 8: 339. Doi: 10.4172/2161-1165.1000339

Copyright: © 2018 Lee HJ. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top